Clinical Trials Directory

Trials / Completed

CompletedNCT01338779

Study of Tolerant Kidney Transplant Recipients

Identification and Mechanistic Investigations of Tolerant Transplant Recipients

Status
Completed
Phase
Study type
Observational
Enrollment
197 (actual)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this multi-center (observational) registry study is to establish a database of clinical and laboratory information that may help to identify any unique characteristics of tolerant participants that differ from participants who reject their kidney after discontinuing immunosuppressive drugs.

Detailed description

Following kidney (renal) transplantation, one possible complication is rejection of the new kidney. This occurs as a results of the body's immune system attacking (or rejecting) the newly transplanted kidney. After transplant, medicines known as "immunosuppressive" or "anti-rejection" drugs are given to transplant recipients to help prevent rejection of the transplanted kidney. If a transplant recipient stops taking these medicines, they almost always reject their transplanted kidney. However, in some exceptionally rare instances, transplant recipients who stop taking these drugs do not reject their kidney, and the kidney keeps working. The recipients are said at that point to "tolerate" the transplanted kidney, and this condition is referred to as "tolerance". In this study, participants will be asked to provide consent for the collection of extensive demographic and clinical information; medical histories; and blood and urine samples. Blood and urine samples collected will be used to perform specific assays to help define mechanisms of tolerance. Originally the study included 11 groups as listed; however, at present only groups 1,4, and 8 remain active. Whereas the initial study duration was 6 years, this was extended to 11 years in order to follow over more extended time a B cell signature identified for tolerant kidney subjects and how this signature may change. (Refer to publications section: Newell, Kirk et al, J Clin Invest. 2010).

Conditions

Timeline

Start date
2004-05-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2011-04-20
Last updated
2016-09-30

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01338779. Inclusion in this directory is not an endorsement.

Study of Tolerant Kidney Transplant Recipients (NCT01338779) · Clinical Trials Directory